Am. J. Respir. Crit. Care Med., Vol 153, No. 4, 04 1996, 1214-1221.
Effects of depletion of cells bearing the interleukin-2 receptor on immunoglobulin production and allergic airway responses in the rat
PM Renzi, JP Yang, T Diamantstein and JG Martin
Respiratory Health Network of Centres of Excellence of Canada, Montreal, Quebec.
Lymphocytes, key cells in chronic inflammation, are increased in the
airways of asthmatics and have increased expression of the interleukin- 2
(IL-2) receptor, a sign of activation. We determined the effects of
depleting cells bearing IL-2 receptors on immunoglobulin (Ig) production,
airway inflammation, and airway responses after antigen challenge of Brown
Norway rats that were sensitized to ovalbumin (OA). Both control and ART-18
(antirat IL-2 receptor) antibodies inhibited plasma specific IgE and the
early (ER) and late (LR) airway responses to antigen when given from zero
to 14 d after sensitization. When ART- 18 was administered from 4 to 14 d
after sensitization and compared with control animals, it inhibited OA
specific IgE production from Day 21 onward, but it increased total IgE and
specific IgG. These changes followed a significant increase in blood CD4+
lymphocytes (%) in ART-18- treated animals 14 d after sensitization. The
same protocol of administration did not affect Ig levels at 14 d, but it
decreased neutrophil influx into the lungs 8 h after antigen challenge
without any effects on the ER and LR. Administration of ART-18 at the time
of antigen challenge did not affect the subsequent airway inflammation or
the increased responsiveness to methacholine that occurs 32 h after antigen
challenge. In summary, depletion of IL-2-receptor-bearing cells affects
lymphocyte subsets and immunoglobulin production and it decreases the
influx of neutrophils into the lungs 8 h after OA challenge, but it does
not significantly inhibit the ER, LR, or increased airway responsiveness
after antigen challenge.
This article has been cited by other articles:

|
 |

|
 |
 
A. Linden, M. Laan, and G. P. Anderson
Neutrophils, interleukin-17A and lung disease
Eur. Respir. J.,
January 1, 2005;
25(1):
159 - 172.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Laan, O. Prause, M. Miyamoto, M. Sjostrand, A.M. Hytonen, T. Kaneko, J. Lotvall, and A. Linden
A role of GM-CSF in the accumulation of neutrophils in the airways caused by IL-17 and TNF-{alpha}
Eur. Respir. J.,
March 1, 2003;
21(3):
387 - 393.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. W. Hellings, A. Kasran, Z. Liu, P. Vandekerckhove, A. Wuyts, L. Overbergh, C. Mathieu, and J. L. Ceuppens
Interleukin-17 Orchestrates the Granulocyte Influx into Airways after Allergen Inhalation in a Mouse Model of Allergic Asthma
Am. J. Respir. Cell Mol. Biol.,
January 1, 2003;
28(1):
42 - 50.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Laan, L. Palmberg, K. Larsson, and A. Linden
Free, soluble interleukin-17 protein during severe inflammation in human airways
Eur. Respir. J.,
March 1, 2002;
19(3):
534 - 537.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Laan, Z.-H. Cui, H. Hoshino, J. Lotvall, M. Sjostrand, D. C. Gruenert, B.-E. Skoogh, and A. Linden
Neutrophil Recruitment by Human IL-17 Via C-X-C Chemokine Release in the Airways
J. Immunol.,
February 15, 1999;
162(4):
2347 - 2352.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 American Thoracic Society
|
|
|